首页> 美国卫生研究院文献>eLife >Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
【2h】

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes

机译:深度学习检测含有诱导多能干细胞衍生的心肌细胞的高含量筛网中的心脏毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug-induced cardiotoxicity and hepatotoxicity are major causes of drug attrition. To decrease late-stage drug attrition, pharmaceutical and biotechnology industries need to establish biologically relevant models that use phenotypic screening to detect drug-induced toxicity in vitro. In this study, we sought to rapidly detect patterns of cardiotoxicity using high-content image analysis with deep learning and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). We screened a library of 1280 bioactive compounds and identified those with potential cardiotoxic liabilities in iPSC-CMs using a single-parameter score based on deep learning. Compounds demonstrating cardiotoxicity in iPSC-CMs included DNA intercalators, ion channel blockers, epidermal growth factor receptor, cyclin-dependent kinase, and multi-kinase inhibitors. We also screened a diverse library of molecules with unknown targets and identified chemical frameworks that show cardiotoxic signal in iPSC-CMs. By using this screening approach during target discovery and lead optimization, we can de-risk early-stage drug discovery. We show that the broad applicability of combining deep learning with iPSC technology is an effective way to interrogate cellular phenotypes and identify drugs that may protect against diseased phenotypes and deleterious mutations.
机译:药物诱导的心脏毒性和肝毒性是药物磨损的主要原因。为了减少后期药物磨损,制药和生物技术产业需要建立生物相关模型,这些模型使用表型筛选来检测体外药物诱导的毒性。在这项研究中,我们试图利用高含量的图像分析快速检测心肌毒性的模式,深入学习和诱导多能干细胞衍生心肌细胞(IPSC-CM)。我们筛选了1280个生物活性化合物的库,并使用基于深度学习的单个参数分数鉴定了IPSC-CMS中具有潜在心脏毒性负债的人。在IPSC-CM中展示心脏毒性的化合物包括DNA嵌入剂,离子通道阻滞剂,表皮生长因子受体,细胞周期蛋白依赖性激酶和多激酶抑制剂。我们还筛选了具有未知目标的多样化分子库,并确定了在IPSC-CMS中显示出心脏毒性信号的化学框架。通过在目标发现和铅优化期间使用这种筛选方法,我们可以降低早期药物发现。我们表明,将深度学习与IPSC技术相结合的广泛适用性是询问细胞表型的有效方法,并鉴定可能保护患病表型和有害突变的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号